Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks
Conditions
Prostate Cancer
Conditions: official terms
Prostatic Neoplasms
Conditions: Keywords
Prostate cancer, Decision
Study Type
Interventional
Study Phase
Phase 3
Study Design
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label
Intervention
Name: Personal Patient Profile - Prostate (P3P) Type: Behavioral
Name: Standard prostate cancer information websites Type: Behavioral
Overall Status
Recruiting
Summary
The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Male
Criteria: Inclusion Criteria:

- Biopsy-proven diagnosis of prostate cancer, T1 or T2 of any risk level

- Biopsy done at enrolling site

- Upcoming appointment with consulting specialist at enrolling study site

- Able to read, write, understand English

Exclusion Criteria:

- Two or more post-biopsy specialist consults

- Begun treatment (or active surveillance)
Locations
Kaiser Permanente - Souther California
Downey, California, United States
Status: Recruiting
Contact: Cynthia Brown, RN, MSN, CCRP - 626-564-7845 - cynthia.a.brown@kp.org
Kaiser Permanente - Southern California
Los Angeles, California, United States
Status: Recruiting
Contact: Cynthia Brown, RN, MSN, CCRP - 626-564-7845 - cynthia.a.brown@kp.org
Emory Healthcare
Atlanta, Georgia, United States
Status: Recruiting
Contact: Mersiha Torlek, MPH, CCRP - 404-778-4823 - mhotic@emory.edu
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Status: Recruiting
Contact: Catrina Crociani - ccrociani@bidmc.harvard.edu
Start Date
September 2013
Completion Date
August 2016
Sponsors
Dana-Farber Cancer Institute
Source
Dana-Farber Cancer Institute
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page